G
Guest
This is what we call evidence-based medicine. This is how the decisions are made about what are the proper dosages, which valve to use etc. For an article to be published in a journal it must be peer-reviewed. The reviewers check to see if what they did justifies the conclusions that they make. After it is published, readers have a chance to write and make comments either in support of disputing what was written. These thing are then considered by panels who make recommendations for people practicing in the field. Hopefully your doctor chose your valve on this basis and not on which sales rep made the last call!!
Annals of Thoracic Surgery February 2002 published this study from Japan about the CarboMedics valve. There were 468 patients aged 13 to 76 years included. 239 aortic valves, 167 mitral valves and 62 with both. The follow-up time mean was 4.4 years (rather short) and covered 2,016 patient years (again not real long but not too bad either). A patient year is one patient followed for 1 year
Here is the part of interest to me - the target level for their warfarin was 1.5 to 2.8.
The results 1.2% died before leaving the hospital. This is a 7-year actuarial analysis (maybe somebody else can explain that).
87% were alive
6% died from valve-related causes
Valve site % who had clotting events % who bled
Aortic 18 12
Mitral 5 9
Both 4 15
2% needed an additional valve operation.
The percentage of aortic people with problems seems high since we usually thing that they could get by with a lower INR, but that is the data.
Remember that this was done in Japan. There may be some slight difference in applying the results to other ethnic groups, but thi shas never been proven.
Annals of Thoracic Surgery February 2002 published this study from Japan about the CarboMedics valve. There were 468 patients aged 13 to 76 years included. 239 aortic valves, 167 mitral valves and 62 with both. The follow-up time mean was 4.4 years (rather short) and covered 2,016 patient years (again not real long but not too bad either). A patient year is one patient followed for 1 year
Here is the part of interest to me - the target level for their warfarin was 1.5 to 2.8.
The results 1.2% died before leaving the hospital. This is a 7-year actuarial analysis (maybe somebody else can explain that).
87% were alive
6% died from valve-related causes
Valve site % who had clotting events % who bled
Aortic 18 12
Mitral 5 9
Both 4 15
2% needed an additional valve operation.
The percentage of aortic people with problems seems high since we usually thing that they could get by with a lower INR, but that is the data.
Remember that this was done in Japan. There may be some slight difference in applying the results to other ethnic groups, but thi shas never been proven.